Data gathered: December 7
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | 1,000 0% |
|
|
Sentiment | 96 11.6% |
|
|
Webpage traffic | 936,000 -7.3% |
|
|
Employee Rating | 79 0% |
|
|
Google Adspend | $4,022 365% |
|
|
Google Trends | 28 -59.4% |
|
|
Linkedin Employees | 52,820 N/A |
|
|
Lobbying Cost | $250,000 0% |
|
|
Patents | 476 0% |
|
|
4chan Mentions | 0% |
|
|
Facebook Engagement | 657 3.6% |
|
|
Facebook followers | 36,859 0% |
|
|
Stocktwits Mentions | 65 441.7% |
|
|
Stocktwits Subscribers | 30,327 0.1% |
|
|
Twitter Followers | 79,296 0% |
|
|
Youtube Subscribers | 5,720 0.2% |
|
|
Instagram Followers | 32,150 0.1% |
|
|
News Mentions | 3 50% |
|
|
Reddit Mentions | 2 0% |
|
|
ESG | 82 0% |
|
|
Business outlook | 72 0% |
|
In the news
![]() |
PRESS DIGEST- Wall Street Journal - Dec. 7December 6 - Yahoo |
Cerevel options trading surge before AbbVie deal news raises eyebrowsDecember 6 - Yahoo |
|
![]() |
The Magnificent 7 Aren't So Magnificent Right Now, BuyDecember 6 - SeekingAlpha |
AbbVie to buy drug developer Cerevel for $8.7 billionDecember 6 - Yahoo |
|
AbbVie to Buy Cerevel Therapeutics for $8.7 BillionDecember 6 - Yahoo |
|
![]() |
UPDATE 3-AbbVie to buy drug developer Cerevel for $8.7 billionDecember 6 - Yahoo |
About AbbVie
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

Price | $147.97 |
Target Price | Sign up |
Market Cap | $257B |
Dividend Yield | 0.0429 |
Industry | Drug Manufacturers |
Similar companies
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 13.9B | 11.9B | 2.07B | 1.78B | 4.51B |
Q2 '23 | 13.9B | 9.61B | 4.26B | 2.02B | 5.26B |
Q1 '23 | 12.2B | 9.68B | 2.54B | 239M | 2.97B |
Q4 '22 | 15.1B | 4.17B | 11B | 2.47B | 5.49B |
Q3 '22 | 14.8B | 11.1B | 3.72B | 3.95B | 6.96B |
Insider Transactions
GONZALEZ RICHARD A filed to sell 565,294 shares at $148.6. August 2 '23 |
Sorg Elaine K. filed to sell 35,330 shares at $165. April 27 '23 |
Sorg Elaine K. filed to sell 35,330 shares at $162. April 19 '23 |
Siatis Perry C filed to sell 10,377 shares at $160. April 5 '23 |
Sorg Elaine K. filed to sell 42,829 shares at $160. April 5 '23 |